Technology | Artificial Intelligence | March 19, 2018

Philips Launches HealthSuite Insights AI Platform for Healthcare

Online marketplace offers curated, readily available AI assets for license

Philips Launches HealthSuite Insights AI Platform for Healthcare

March 19, 2018 — Philips recently announced the launch of HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. Making their debut at the 2018 Healthcare Information and Management Systems Society Conference and Exhibition (HIMSS18), March 5-9 in Las Vegas, HealthSuite Insights gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry's first ecosystem where curated AI assets from Philips and others are readily available for license.

AI-based solutions have great potential to improve patient outcomes and care efficiency, according to Philips. However, developing and deploying AI solutions for healthcare use cases can be time consuming, resource intensive and expensive. HealthSuite Insights eases the logistical challenges of deploying AI solutions in research and clinical environments. It accelerates the development of analytics solutions, and reduces development and total cost of AI solutions.

"The quality of your AI is only as good as the quality of the data you feed into it," said Jeroen Tas, Chief Innovation & Strategy Officer Philips. "We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers.” He added that the platform gives users the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency.

The tools and technologies available through HealthSuite Insights already enable the machine learning and deep learning applications in Philips' diagnostic imaging solutions, patient monitoring solutions, and oncology and genomics offerings. Enabled by the platform, Philips leverages AI across these offerings, by combining it with other technologies and a deep understanding of the clinical, operational and personal context to augment care professionals and patients/consumers.

Philips' Insights Marketplace initially offers assets supplied by Philips – including assets developed by scientists at Philips Research. Medically validated Philips assets will be added later this year. In late 2018, the Insights Marketplace will be further expanded to include assets submitted by third parties.

AI assets built using the Insights Platform are designed to be secure regardless of the execution environment, with sophisticated identity and access management, integrated blockchain services, and data collection and management services built in. The Insights platform can be deployed on a healthcare cloud infrastructure such as the Philips HealthSuite Digital Platform, or on premise at a provider site.

For more information: www.usa.philips.com/healthcare

 

Related Content

HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | April 16, 2019
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo...